Life Sciences Blog

Embryonic stem cells provide hope for treating the blind

Posted on July 23rd, by Michael Shapiro-Barr

Scientists have successfully treated blindness in mice, by integrating lab grown light-sensitive retinal cells into the eyes of the blind mice.  The light-sensitive nerve cells, called photoreceptors, were grown by scientists from embryonic stem cells.  Loss of these nerve cells is the primary cause of blindness for age-related macular degeneration, retinitis pigmentosa and diabetes-related blindness.

Read More



Leave a Reply

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Media Quotes

  • Mercedes Meyer, a patent lawyer with the firm Drinker Biddle in Washington, D.C., said the Supreme Court’s failure to provide “bright-line guidance”—a ruling that would settle once-and-for all whether patent settlements are legal or not—means there’s “really no difference now than what was going on.” Mercedes Meyer
    CNBC: High Court Allows FTC to Challenge 'Pay-to-Delay' Generics

From the Blog

Navigating the Isolated DNA Patent Eligibility Jungle
Introduction

For over 150 years the Supreme Court has provided three categories of exceptions to patent eligibility under 35 U.S.C §101:  abstract ideas, laws of...

Drug Import Regulation: On the Brink of Historic Change

On Friday, July 12, 2013, the Food and Drug Administration (FDA) hosted a public meeting to discuss the implementation of the drug supply chain...

This Conversation May Be Recorded

As the pharmaceutical industry changes, it must take note of the impact such change has on employee relations and the potential for lawsuits.  Big...